ClinicalTrials.gov record
Recruiting Phase 2 Interventional

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

ClinicalTrials.gov ID: NCT06951217

Public ClinicalTrials.gov record NCT06951217. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 5:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multinational, Long-Term, Safety and Tolerability, Open-Label Extension Study of Subjects Who Have Participated in Avalyn Pharma Studies of Inhaled Antifibrotic Agents (AP-LTE-008 [SAIL])

Study identification

NCT ID
NCT06951217
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Avalyn Pharma Inc.
Industry
Enrollment
340 participants

Conditions and interventions

Interventions

  • AP01 Combination Product

Combination Product

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 16, 2025
Primary completion
Dec 30, 2031
Completion
Dec 30, 2031
Last update posted
Apr 28, 2026

2025 – 2031

United States locations

U.S. sites
23
U.S. states
18
U.S. cities
20
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35205 Recruiting
University of Southern California Los Angeles California 90033 Recruiting
University of Colorado, Anschutz Medical Campus Aurora Colorado 80045 Recruiting
Renstar Medical Research Ocala Florida 34470 Recruiting
Piedmont Healthcare, Inc. Atlanta Georgia 30309 Recruiting
University of Maryland Baltimore Maryland 21201 Recruiting
Mayo Clinic Rochester Rochester Minnesota 55901 Recruiting
Hannibal Regional Healthcare System, Inc. Hannibal Missouri 63401 Recruiting
Icahn School of Medicine at Mount Sinai New York New York 10029 Recruiting
Columbia University New York New York 10032 Recruiting
Piedmont HealthCare, PA Statesville North Carolina 28625 Recruiting
Southeastern Research Center Winston-Salem North Carolina 27103 Recruiting
University of Cincinnati Cincinnati Ohio 45267 Recruiting
The University of Kansas Medical Center Kansas Ohio 66160 Recruiting
Summit Health Bend Oregon 97701 Recruiting
Thomas Jefferson University Philadelphia Pennsylvania 19107 Recruiting
Temple University Hospital Philadelphia Pennsylvania 19140 Recruiting
Lowcountry Lung and Critical Care, PA Charleston South Carolina 29406 Recruiting
Medical University of South Carolina Charleston South Carolina 29425 Recruiting
Vanderbilt University Medical Center Nashville Tennessee 37204 Recruiting
El Paso Pulmonary Association, P.A. El Paso Texas 79902 Recruiting
Intermountain Medical Center Murray Utah 84107 Recruiting
Inova Healthcare Falls Church Virginia 22042 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06951217, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 28, 2026 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06951217 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →